BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34975255)

  • 1. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia.
    Sharma LK; Dutta D; Sharma N; Kulshreshtha B; Lal S; Sethi R
    J Lab Physicians; 2021 Dec; 13(4):353-357. PubMed ID: 34975255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
    Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and reproductive manifestations of macroprolactinemia.
    Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
    Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PEG precipitation and ultrafiltration treatment for serum macroprolactin in Chinese patients with hyperprolactinemia.
    Ke X; Wang L; Duan L; Yang H; Yin J; Qiu L; Pan H; Gong F; Zhu H
    Clin Chim Acta; 2023 Apr; 544():117358. PubMed ID: 37086942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.
    Hu Y; Ni J; Zhang B; Cheng W; Zhang H; Ye H; Ji L; Lu B; Guan M
    BMC Endocr Disord; 2021 Oct; 21(1):197. PubMed ID: 34620143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
    Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
    Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactinemia: the consequences of a laboratory pitfall.
    Toldy E; Löcsei Z; Szabolcs I; Góth MI; Kneffel P; Szöke D; Kovács GL
    Endocrine; 2003 Dec; 22(3):267-73. PubMed ID: 14709800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinemia in hyperprolactinemic infertile women.
    Thirunavakkarasu K; Dutta P; Sridhar S; Dhaliwal L; Prashad GR; Gainder S; Sachdeva N; Bhansali A
    Endocrine; 2013 Dec; 44(3):750-5. PubMed ID: 23543432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
    Overgaard M; Pedersen SM
    Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
    Shimatsu A; Hattori N
    Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening and detection of patients with macroprolactinemia by application of polyethylene glycol precipitation method].
    Chen YJ; Zhou YL; Xu L; Yan J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 43(2):187-92. PubMed ID: 24782376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM; Smith TP; Gibney J; McKenna TJ
    Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroprolactin: From laboratory to clinical practice.
    Biagetti B; Ferrer Costa R; Alfayate Guerra R; Álvarez García E; Berlanga Escalera E; Casals G; Esteban Salán M; Granada Ibern ML; Gorrín Ramos J; López Lazareno N; Oriola J; Sánchez Martínez PM; Torregrosa Quesada ME; Urgell Rull E; García Lacalle C
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):63-69. PubMed ID: 35232561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
    Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.